Search Within

Vatche Tchekmedyian

Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
Groups
  1. Weinberg Fellows (13)
  2. Department of Medicine (11)
  3. Head and Neck Service (11)
  4. Solid Tumor Oncology Division (11)
  5. Biostatistics Service (9)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Alan Ho (10)
  2. Eric Sherman (10)
  3. David Pfister (9)
  4. Lara Dunn (9)
  5. Sofia Haque (6)
  6. James Fetten (5)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (4)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Blood (1)
  3. Cancer Discovery (1)
  4. International Journal of Cancer (1)
  5. International Journal of Radiation Oncology, Biology, Physics (1)
  6. Journal of Clinical Endocrinology and Metabolism (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (1)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. John Wiley & Sons (1)

More Publishers

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Any day, split halfway: Flexibility in scheduling high-dose cisplatin - A large retrospective review from a high-volume cancer center
    Journal Article

    Kang, J. J.; Tchekmedyian, V.; Mohammed, N.; Rybkin, A.; Kitpanit, S.; Fan, M.; Wang, H.; Lobaugh, S. M.; Zhang, Z.; Lee, A.; more...
    International Journal of Cancer (2021)

    Fulltext@MSK | Save
  • SWI/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies
    Journal Article

    Saqcena, M.; Leandro-Garcia, L. J.; Maag, J. L. V.; Tchekmedyian, V.; Krishnamoorthy, G. P.; Tamarapu, P. P.; Tiedje, V.; Reuter, V.; Knauf, J. A.; de Stanchina, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Split high-dose cisplatin: An alternate high-dose cisplatin administration schedule for definitive chemoradiation in oropharyngeal cancer
    Meeting Abstract

    Kang, J. J.; Tchekmedyian, V.; Fan, M.; Wang, H.; Kitpanit, S.; Mohamed, N.; Rybkin, A.; Lee, A.; Chen, L.; Yu, Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx
    Meeting Abstract

    Tchekmedyian, V.; Ho, A. L.; Dunn, L.; Fetten, J. V.; Pfister, D. G.; Lobaugh, S.; Zhang, Z.; Kang, J.; Chen, L.; Riaz, N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Morris, L.; Ostrovnaya, I.; Katabi, N.; Haque, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma
    Journal Article

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Baxi, S.; Katabi, N.; Antonescu, C. R.; Ostrovnaya, I.; Haque, S. S.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Katabi, N.; Ni, A.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save